Astagraf XL Interactions
There are 836 drugs known to interact with Astagraf XL (tacrolimus), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 250 are major, 569 are moderate, and 17 are minor.
- View all 836 medications that may interact with Astagraf XL
- View Astagraf XL alcohol/food interactions (2)
- View Astagraf XL disease interactions (7)
Most frequently checked interactions
View interaction reports for Astagraf XL (tacrolimus) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advate (antihemophilic factor)
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- Bactrim (sulfamethoxazole / trimethoprim)
- calcitriol
- carvedilol
- CellCept (mycophenolate mofetil)
- clonidine
- finasteride
- Levemir (insulin detemir)
- losartan
- magnesium oxide
- metoprolol
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- multivitamin
- mycophenolate mofetil
- Myfortic (mycophenolic acid)
- omeprazole
- pravastatin
- prednisone
- Prevacid (lansoprazole)
- Simbrinza (brimonidine / brinzolamide ophthalmic)
- tamsulosin
- timolol
- Travatan Z (travoprost ophthalmic)
- trazodone
- Valcyte (valganciclovir)
Astagraf XL alcohol/food interactions
There are 2 alcohol/food interactions with Astagraf XL (tacrolimus).
Astagraf XL disease interactions
There are 7 disease interactions with Astagraf XL (tacrolimus) which include:
- diabetes mellitus
- hepatic dysfunction
- infections
- QT interval prolongation
- renal dysfunction
- hyperkalemia
- hypertension
More about Astagraf XL (tacrolimus)
- Astagraf XL consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.